1
|
Liu F, Lin Q, Shen S, Li Z, Xie X, Cheng Q, Wang L, Long Y, Wang J, Liu L. Secretion of WNT7A by UC-MSCs assist in promoting the endometrial epithelial regeneration. iScience 2024; 27:109888. [PMID: 38947517 PMCID: PMC11214297 DOI: 10.1016/j.isci.2024.109888] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2024] [Revised: 03/19/2024] [Accepted: 04/30/2024] [Indexed: 07/02/2024] Open
Abstract
Stem cell therapy for intrauterine adhesions (IUAs) has been widely used in clinical treatment. However, intravenous injection lacks sufficient targeting capabilities, while in situ injection poses challenges in ensuring the effective survival of stem cells. Furthermore, the mechanism underlying the interaction between stem cells and endometrial cells in vivo remains poorly understood, and there is a lack of suitable in vitro models for studying these problems. Here, we designed an extracellular matrix (ECM)-adhesion mimic hydrogel for intrauterine administration, which was more effective than direct injection in treating IUAs. Additionally, we analyzed the epithelial-mesenchymal transition (EMT) and confirmed that the activation of endometrial epithelial stem cells is pivotal. Our findings demonstrated that umbilical cord mesenchymal stem cells (UC-MSCs) secrete WNT7A to activate endometrial epithelial stem cells, thereby accelerating regeneration of the endometrial epithelium. Concurrently, under transforming growth factor alpha (TGFA) stimulation secreted by the EMT epithelium, UC-MSCs upregulate E-cadherin while partially implanting into the endometrial epithelium.
Collapse
Affiliation(s)
- Fangbo Liu
- Shanghai Drugability Biomass Product Evaluation Professional Public Service Platform, Center for Pharmacological Evaluation and Research, China State Institute of Pharmaceutical Industry, No. 285 Gebaini Road, Shanghai 201203, China
| | - Qin Lin
- The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, China
- Shanghai Key Laboratory of Embryo Original Diseases, Shanghai 200030, China
| | - Shaolei Shen
- Shanghai Drugability Biomass Product Evaluation Professional Public Service Platform, Center for Pharmacological Evaluation and Research, China State Institute of Pharmaceutical Industry, No. 285 Gebaini Road, Shanghai 201203, China
| | - Zhihong Li
- Shanghai Drugability Biomass Product Evaluation Professional Public Service Platform, Center for Pharmacological Evaluation and Research, China State Institute of Pharmaceutical Industry, No. 285 Gebaini Road, Shanghai 201203, China
| | - Xiaorui Xie
- Shanghai Drugability Biomass Product Evaluation Professional Public Service Platform, Center for Pharmacological Evaluation and Research, China State Institute of Pharmaceutical Industry, No. 285 Gebaini Road, Shanghai 201203, China
| | - Quan Cheng
- Shanghai Drugability Biomass Product Evaluation Professional Public Service Platform, Center for Pharmacological Evaluation and Research, China State Institute of Pharmaceutical Industry, No. 285 Gebaini Road, Shanghai 201203, China
| | - Lan Wang
- Shanghai Drugability Biomass Product Evaluation Professional Public Service Platform, Center for Pharmacological Evaluation and Research, China State Institute of Pharmaceutical Industry, No. 285 Gebaini Road, Shanghai 201203, China
| | - Yin Long
- Department of Traditional Chinese Medicine, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi 710032, China
| | - Juan Wang
- Shanghai Drugability Biomass Product Evaluation Professional Public Service Platform, Center for Pharmacological Evaluation and Research, China State Institute of Pharmaceutical Industry, No. 285 Gebaini Road, Shanghai 201203, China
| | - Li Liu
- Shanghai Drugability Biomass Product Evaluation Professional Public Service Platform, Center for Pharmacological Evaluation and Research, China State Institute of Pharmaceutical Industry, No. 285 Gebaini Road, Shanghai 201203, China
| |
Collapse
|
2
|
Pedro SN, Valente BF, Vilela C, Oliveira H, Almeida A, Freire MG, Silvestre AJ, Freire CS. Switchable adhesive films of pullulan loaded with a deep eutectic solvent-curcumin formulation for the photodynamic treatment of drug-resistant skin infections. Mater Today Bio 2023; 22:100733. [PMID: 37533730 PMCID: PMC10392606 DOI: 10.1016/j.mtbio.2023.100733] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2023] [Revised: 06/30/2023] [Accepted: 07/12/2023] [Indexed: 08/04/2023] Open
Abstract
Antimicrobial photodynamic therapy (aPDT) is a potent tool to surpass the global rise of antimicrobial resistance; still, the effective topical administration of photosensitizers remains a challenge. Biopolymer-based adhesive films can safely extend the residence time of photosensitizers. However, their wide application is narrowed by their limited water absorption capacity and gel strength. In this study, pullulan-based films with a switchable character (from a solid film to an adhesive hydrogel) were developed. This was accomplished by the incorporation of a betaine-based deep eutectic solvent (DES) containing curcumin (4.4 μg.cm-2) into the pullulan films, which tuned the films' skin moisture absorption ability, and therefore they switch into an adhesive hydrogel capable of delivering the photosensitizer. The obtained transparent films presented higher extensibility (elongation at break up to 338.2%) than the pullulan counterparts (6.08%), when stored at 54% of relative humidity, and the corresponding hydrogels a 4-fold higher adhesiveness than commercial hydrogels. These non-cytotoxic adhesives allowed the inactivation (∼5 log reduction), down to the detection limit of the method, of multiresistant strains of Staphylococcus aureus in ex vivo skin samples. Overall, these materials are promising for aPDT in the treatment of resistant skin infections, while being easily removed from the skin.
Collapse
Affiliation(s)
- Sónia N. Pedro
- CICECO - Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, Campus de Santiago, 3810-193, Aveiro, Portugal
| | - Bruno F.A. Valente
- CICECO - Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, Campus de Santiago, 3810-193, Aveiro, Portugal
| | - Carla Vilela
- CICECO - Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, Campus de Santiago, 3810-193, Aveiro, Portugal
| | - Helena Oliveira
- CESAM, Department of Biology, University of Aveiro, Campus de Santiago, 3810-193, Aveiro, Portugal
| | - Adelaide Almeida
- CESAM, Department of Biology, University of Aveiro, Campus de Santiago, 3810-193, Aveiro, Portugal
| | - Mara G. Freire
- CICECO - Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, Campus de Santiago, 3810-193, Aveiro, Portugal
| | - Armando J.D. Silvestre
- CICECO - Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, Campus de Santiago, 3810-193, Aveiro, Portugal
| | - Carmen S.R. Freire
- CICECO - Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, Campus de Santiago, 3810-193, Aveiro, Portugal
| |
Collapse
|
3
|
S A Bento C, Gaspar MC, Coimbra P, de Sousa HC, E M Braga M. A review of conventional and emerging technologies for hydrogels sterilization. Int J Pharm 2023; 634:122671. [PMID: 36736965 DOI: 10.1016/j.ijpharm.2023.122671] [Citation(s) in RCA: 16] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2022] [Revised: 01/26/2023] [Accepted: 01/28/2023] [Indexed: 02/04/2023]
Abstract
Hydrogels are extensively used in the biomedical field, as drug delivery systems, wound dressings, contact lenses or as scaffolds for tissue engineering. Due to their polymeric nature and the presence of high amounts of water in their structure, hydrogels generally present high sensitivity to terminal sterilization. The establishment of an efficient sterilization protocol that does not compromise the functional properties of the hydrogels is one of the challenges faced by researchers when developing a hydrogel for a specific application. Yet, until very recently this aspect was largely ignored in the literature. The present paper reviews the state of literature concerning hydrogels sterilization, compiling the main findings. Conventional terminal sterilization methods (heat sterilization, radiation sterilization, and gas sterilization) as well as emerging sterilization techniques (ozone, supercritical carbon dioxide) are covered. Considerations about aseptic processing are also included. Additionally, and as a framework, hydrogels' polymeric materials, types of networks, and main biomedical applications are summarily described.
Collapse
Affiliation(s)
- Cristiana S A Bento
- University of Coimbra, CIEPQPF, Department of Chemical Engineering, Rua Sílvio Lima, Pólo II - Pinhal de Marrocos, 3030-790 Coimbra, Portugal
| | - Marisa C Gaspar
- University of Coimbra, CIEPQPF, Department of Chemical Engineering, Rua Sílvio Lima, Pólo II - Pinhal de Marrocos, 3030-790 Coimbra, Portugal; Center for Innovative Care and Health Technology (ciTechCare), Polytechnic of Leiria, 2410-541 Leiria, Portugal
| | - Patrícia Coimbra
- University of Coimbra, CIEPQPF, Department of Chemical Engineering, Rua Sílvio Lima, Pólo II - Pinhal de Marrocos, 3030-790 Coimbra, Portugal
| | - Hermínio C de Sousa
- University of Coimbra, CIEPQPF, Department of Chemical Engineering, Rua Sílvio Lima, Pólo II - Pinhal de Marrocos, 3030-790 Coimbra, Portugal
| | - Mara E M Braga
- University of Coimbra, CIEPQPF, Department of Chemical Engineering, Rua Sílvio Lima, Pólo II - Pinhal de Marrocos, 3030-790 Coimbra, Portugal.
| |
Collapse
|
4
|
Fiqri M, Alhidayah, Nirmayanti, Athiyyah U, Layadi P, Angeleve Fadjar TG, Permana AD. Enhanced localization of cefazoline sodium in the ocular tissue using thermosensitive-mucoadhesive hydrogels: Formulation development, hemocompatibility and in vivo irritation studies. J Drug Deliv Sci Technol 2022. [DOI: 10.1016/j.jddst.2022.103763] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
5
|
Jabeen N, Sohail M, Shah SA, Mahmood A, Khan S, Kashif MUR, Khaliq T. Silymarin nanocrystals-laden chondroitin sulphate-based thermoreversible hydrogels; A promising approach for bioavailability enhancement. Int J Biol Macromol 2022; 218:456-472. [PMID: 35872320 DOI: 10.1016/j.ijbiomac.2022.07.114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2022] [Revised: 07/12/2022] [Accepted: 07/16/2022] [Indexed: 11/25/2022]
Abstract
Hydrogels has gained tremendous interest as a controlled release drug delivery. However, currently it is a big challenge to attain high drug-loading as well as stable and sustained release of hydrophobic drugs. The poor aqueous solubility and low bioavailability of many drugs have driven the need for research in new formulations. This manuscript hypothesized that incorporation of nanocrystals of hydrophobic drug, such as silymarin into thermoreversible hydrogel could be a solution to these problems. Herein, we prepared nanocrystals of silymarin by antisolvent precipitation technique and characterized for morphology, particle size, polydispersity index (PDI) and zeta potential. Moreover, physical cross-linking of hydrogel formulations based on chondroitin sulphate (CS), kappa-Carrageenan (κ-Cr) and Pluronic® F127 was confirmed by Fourier transformed infrared spectroscopy (FT-IR). The hydrogel gelation time and temperature of optimized hydrogel was 14 ± 3.2 s and 34 ± 0.6 °C, respectively. The release data revealed controlled release of silymarin up to 48 h and in-vivo pharmacokinetic profiling was done in rabbits and further analyzed by high-performance liquid chromatography (HPLC). It is believed that the nanocrystals loaded thermoreversible injectable hydrogel system fabricated in this study provides high drug loading as well as controlled and stable release of hydrophobic drug for extended period.
Collapse
Affiliation(s)
- Nazish Jabeen
- Department of Pharmacy, COMSATS University, Islamabad, Abbottabad Campus, 22010, Pakistan
| | - Muhammad Sohail
- Department of Pharmacy, COMSATS University, Islamabad, Abbottabad Campus, 22010, Pakistan.
| | - Syed Ahmed Shah
- Department of Pharmacy, COMSATS University, Islamabad, Abbottabad Campus, 22010, Pakistan; Faculty of Pharmacy, Superior University, Lahore, Punjab-Pakistan
| | - Arshad Mahmood
- Collage of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emirates; AAU Health and Biomedical Research Center, Al Ain University, Abu Dhabi, United Arab Emirates
| | - Shahzeb Khan
- Department of Pharmacy, University of Malakand, Lower Dir, KPK, Pakistan
| | | | - Touba Khaliq
- Department of Pharmacy, COMSATS University, Islamabad, Abbottabad Campus, 22010, Pakistan
| |
Collapse
|
6
|
Lucena MDA, Ramos IFDS, Geronço MS, de Araújo R, da Silva Filho FL, da Silva LMLR, de Sousa RWR, Ferreira PMP, Osajima JA, Silva-Filho EC, Rizzo MDS, Ribeiro AB, da Costa MP. Biopolymer from Water Kefir as a Potential Clean-Label Ingredient for Health Applications: Evaluation of New Properties. MOLECULES (BASEL, SWITZERLAND) 2022; 27:molecules27123895. [PMID: 35745016 PMCID: PMC9231297 DOI: 10.3390/molecules27123895] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/13/2022] [Revised: 06/14/2022] [Accepted: 06/15/2022] [Indexed: 11/23/2022]
Abstract
The present work aimed to characterize the exopolysaccharide obtained from water kefir grains (EPSwk), a symbiotic association of probiotic microorganisms. New findings of the technological, mechanical, and biological properties of the sample were studied. The EPSwk polymer presented an Mw of 6.35 × 105 Da. The biopolymer also showed microcrystalline structure and characteristic thermal stability with maximum thermal degradation at 250 °C. The analysis of the monosaccharides of the EPSwk by gas chromatography demonstrated that the material is composed of glucose units (98 mol%). Additionally, EPSwk exhibited excellent emulsifying properties, film-forming ability, a low photodegradation rate (3.8%), and good mucoadhesive properties (adhesion Fmax of 1.065 N). EPSwk presented cytocompatibility and antibacterial activity against Escherichia coli and Staphylococcus aureus. The results of this study expand the potential application of the exopolysaccharide from water kefir as a potential clean-label raw material for pharmaceutical, biomedical, and cosmetic applications.
Collapse
Affiliation(s)
- Monalisa de Alencar Lucena
- Materials Science and Engineering Graduate Program, Federal University of Piauí, Teresina 64049-550, PI, Brazil; (M.d.A.L.); (I.F.d.S.R.); (M.S.G.); (R.d.A.); (J.A.O.); (E.C.S.-F.); (M.P.d.C.)
| | - Igor Frederico da Silveira Ramos
- Materials Science and Engineering Graduate Program, Federal University of Piauí, Teresina 64049-550, PI, Brazil; (M.d.A.L.); (I.F.d.S.R.); (M.S.G.); (R.d.A.); (J.A.O.); (E.C.S.-F.); (M.P.d.C.)
| | - Maurycyo Silva Geronço
- Materials Science and Engineering Graduate Program, Federal University of Piauí, Teresina 64049-550, PI, Brazil; (M.d.A.L.); (I.F.d.S.R.); (M.S.G.); (R.d.A.); (J.A.O.); (E.C.S.-F.); (M.P.d.C.)
| | - Ricardo de Araújo
- Materials Science and Engineering Graduate Program, Federal University of Piauí, Teresina 64049-550, PI, Brazil; (M.d.A.L.); (I.F.d.S.R.); (M.S.G.); (R.d.A.); (J.A.O.); (E.C.S.-F.); (M.P.d.C.)
| | | | - Luís Manuel Lopes Rodrigues da Silva
- CPIRN-UDI/IPG—Centro de Potencial e Inovação em Recursos Naturais, Unidade de Investigação para o Desenvolvimento do Interior do Instituto Politécnico da Guarda, 6300-559 Guarda, Portugal;
| | - Rayran Walter Ramos de Sousa
- Laboratory of Experimental Cancerology (LabCancer), Department of Biophysics and Physiology, Federal University of Piauí, Teresina 64049-550, PI, Brazil; (R.W.R.d.S.); (P.M.P.F.)
- Pharmaceutical Sciences Graduate Program, Federal University of Piauí, Teresina 64049-550, PI, Brazil;
| | - Paulo Michel Pinheiro Ferreira
- Laboratory of Experimental Cancerology (LabCancer), Department of Biophysics and Physiology, Federal University of Piauí, Teresina 64049-550, PI, Brazil; (R.W.R.d.S.); (P.M.P.F.)
- Pharmaceutical Sciences Graduate Program, Federal University of Piauí, Teresina 64049-550, PI, Brazil;
| | - Josy Anteveli Osajima
- Materials Science and Engineering Graduate Program, Federal University of Piauí, Teresina 64049-550, PI, Brazil; (M.d.A.L.); (I.F.d.S.R.); (M.S.G.); (R.d.A.); (J.A.O.); (E.C.S.-F.); (M.P.d.C.)
| | - Edson Cavalcanti Silva-Filho
- Materials Science and Engineering Graduate Program, Federal University of Piauí, Teresina 64049-550, PI, Brazil; (M.d.A.L.); (I.F.d.S.R.); (M.S.G.); (R.d.A.); (J.A.O.); (E.C.S.-F.); (M.P.d.C.)
| | - Márcia dos Santos Rizzo
- Pharmaceutical Sciences Graduate Program, Federal University of Piauí, Teresina 64049-550, PI, Brazil;
| | - Alessandra Braga Ribeiro
- CBQF—Centro de Biotecnologia e Química Fina—Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal
- Correspondence:
| | - Marcilia Pinheiro da Costa
- Materials Science and Engineering Graduate Program, Federal University of Piauí, Teresina 64049-550, PI, Brazil; (M.d.A.L.); (I.F.d.S.R.); (M.S.G.); (R.d.A.); (J.A.O.); (E.C.S.-F.); (M.P.d.C.)
- College of Pharmacy, Federal University of Piauí, Teresina 64049-550, PI, Brazil;
- Pharmaceutical Sciences Graduate Program, Federal University of Piauí, Teresina 64049-550, PI, Brazil;
| |
Collapse
|
7
|
Kiseleva M, Omar MM, Boisselier É, Selivanova SV, Fortin MA. A Three-Dimensional Printable Hydrogel Formulation for the Local Delivery of Therapeutic Nanoparticles to Cervical Cancer. ACS Biomater Sci Eng 2022; 8:1200-1214. [PMID: 35226460 DOI: 10.1021/acsbiomaterials.1c01399] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Cervical cancer is the fourth most common malignancy among women. Compared to other types of cancer, therapeutic agents can be administrated locally at the mucosal vaginal membrane. Thermosensitive gels have been developed over the years for contraception or for the treatment of bacterial, fungal, and sexually transmitted infections. These formulations often carry therapeutic nanoparticles and are now being considered in the arsenal of tools for oncology. They can also be three-dimensionally (3D) printed for a better geometrical adjustment to the anatomy of the patient, thus enhancing the local delivery treatment. In this study, a localized delivery system composed of a Pluronic F127-alginate hydrogel with efficient nanoparticle (NP) release properties was prepared for intravaginal application procedures. The kinetics of hydrogel degradation and its NP releasing properties were demonstrated with ultrasmall gold nanoparticles (∼80% of encapsulated AuNPs released in 48 h). The mucoadhesive properties of the hydrogel formulation were assayed by the periodic acid/Schiff reagent staining, which revealed that 19% of mucins were adsorbed on the gel's surface. The hydrogel formulation was tested for cytocompatibility in three cell lines (HeLa, CRL 2616, and BT-474; no sign of cytotoxicity revealed). The release of AuNPs from the hydrogel and their accumulation in vaginal membranes were quantitatively measured in vitro/ex vivo with positron emission tomography, a highly sensitive modality allowing real-time imaging of nanoparticle diffusion (lag time to start of permeation of 3.3 h, 47% of AuNPs accumulated in the mucosa after 42 h). Finally, the potential of the AuNP-containing Pluronic F127-alginate hydrogel for 3D printing was demonstrated, and the geometrical precision of the 3D printed systems was measured by magnetic resonance imaging (<0.5 mm precision; deviation from the design values <2.5%). In summary, this study demonstrates the potential of Pluronic F127-alginate formulations for the topical administration of NP-releasing gels applied to vaginal wall therapy. This technology could open new possibilities for photothermal and radiosensitizing oncology applications.
Collapse
Affiliation(s)
- Mariia Kiseleva
- Département de Génie des Mines, de la Métallurgie et des Matériaux, Centre de Recherche sur les Matériaux Avancés (CERMA), Université Laval, Québec G1V 0A6, Canada.,Axe Médecine Régénératrice, Centre de Recherche du CHU de Québec - Université Laval, 2705, boul. Laurier (T1-61a), Québec G1V 4G2, Canada
| | - Mahmoud M Omar
- Département de Génie des Mines, de la Métallurgie et des Matériaux, Centre de Recherche sur les Matériaux Avancés (CERMA), Université Laval, Québec G1V 0A6, Canada.,Axe Médecine Régénératrice, Centre de Recherche du CHU de Québec - Université Laval, 2705, boul. Laurier (T1-61a), Québec G1V 4G2, Canada
| | - Élodie Boisselier
- Axe Médecine Régénératrice, Centre de Recherche du CHU de Québec - Université Laval, 2705, boul. Laurier (T1-61a), Québec G1V 4G2, Canada.,Département d'Ophtalmologie, Faculté de Médecine, Centre de Recherche sur les 1022 Matériaux Avancés (CERMA) and CUO-Recherche, Université Laval, Québec G3K 1A3, Canada
| | - Svetlana V Selivanova
- Faculty of Pharmacy, Université Laval, Québec G1V 0A6, Canada.,Axe Oncologie, Centre de Recherche du CHU de Québec - Université Laval, Québec G1R 3S3, Canada
| | - Marc-André Fortin
- Département de Génie des Mines, de la Métallurgie et des Matériaux, Centre de Recherche sur les Matériaux Avancés (CERMA), Université Laval, Québec G1V 0A6, Canada.,Axe Médecine Régénératrice, Centre de Recherche du CHU de Québec - Université Laval, 2705, boul. Laurier (T1-61a), Québec G1V 4G2, Canada
| |
Collapse
|
8
|
Self-adaptive Polymer Reactor Made of Flytrap-Inspired Catalytic Bi-layers, Capable of Single-Tandem-Single Triple-Shift Catalytic Ability. J Inorg Organomet Polym Mater 2022. [DOI: 10.1007/s10904-021-02191-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
9
|
Viswanath DI, Liu HC, Huston DP, Chua CYX, Grattoni A. Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines. Biomaterials 2022; 280:121297. [PMID: 34902729 PMCID: PMC8725170 DOI: 10.1016/j.biomaterials.2021.121297] [Citation(s) in RCA: 22] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2021] [Revised: 11/19/2021] [Accepted: 11/29/2021] [Indexed: 01/03/2023]
Abstract
Landmark successes in oncoimmunology have led to development of therapeutics boosting the host immune system to eradicate local and distant tumors with impactful tumor reduction in a subset of patients. However, current immunotherapy modalities often demonstrate limited success when involving immunologically cold tumors and solid tumors. Here, we describe the role of various biomaterials to formulate cancer vaccines as a form of cancer immunotherapy, seeking to utilize the host immune system to activate and expand tumor-specific T cells. Biomaterial-based cancer vaccines enhance the cancer-immunity cycle by harnessing cellular recruitment and activation against tumor-specific antigens. In this review, we discuss biomaterial-based vaccine strategies to induce lymphocytic responses necessary to mediate anti-tumor immunity. We focus on strategies that selectively attract dendritic cells via immunostimulatory gradients, activate them against presented tumor-specific antigens, and induce effective cross-presentation to T cells in secondary lymphoid organs, thereby generating immunity. We posit that personalized cancer vaccines are promising targets to generate long-term systemic immunity against patient- and tumor-specific antigens to ensure long-term cancer remission.
Collapse
Affiliation(s)
- Dixita Ishani Viswanath
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, USA; Texas A&M University College of Medicine, Bryan & Houston, TX, USA
| | - Hsuan-Chen Liu
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, USA
| | - David P Huston
- Texas A&M University College of Medicine, Bryan & Houston, TX, USA
| | | | - Alessandro Grattoni
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, USA; Department of Surgery, Houston Methodist Hospital, Houston, TX, USA; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, USA.
| |
Collapse
|
10
|
Veiga A, Silva IV, Duarte MM, Oliveira AL. Current Trends on Protein Driven Bioinks for 3D Printing. Pharmaceutics 2021; 13:1444. [PMID: 34575521 PMCID: PMC8471984 DOI: 10.3390/pharmaceutics13091444] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2021] [Revised: 09/03/2021] [Accepted: 09/06/2021] [Indexed: 02/07/2023] Open
Abstract
In the last decade, three-dimensional (3D) extrusion bioprinting has been on the top trend for innovative technologies in the field of biomedical engineering. In particular, protein-based bioinks such as collagen, gelatin, silk fibroin, elastic, fibrin and protein complexes based on decellularized extracellular matrix (dECM) are receiving increasing attention. This current interest is the result of protein's tunable properties, biocompatibility, environmentally friendly nature and possibility to provide cells with the adequate cues, mimicking the extracellular matrix's function. In this review we describe the most relevant stages of the development of a protein-driven bioink. The most popular formulations, molecular weights and extraction methods are covered. The different crosslinking methods used in protein bioinks, the formulation with other polymeric systems or molecules of interest as well as the bioprinting settings are herein highlighted. The cell embedding procedures, the in vitro, in vivo, in situ studies and final applications are also discussed. Finally, we approach the development and optimization of bioinks from a sequential perspective, discussing the relevance of each parameter during the pre-processing, processing, and post-processing stages of technological development. Through this approach the present review expects to provide, in a sequential manner, helpful methodological guidelines for the development of novel bioinks.
Collapse
Affiliation(s)
- Anabela Veiga
- CBQF—Centro de Biotecnologia e Química Fina—Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, 4169-005 Porto, Portugal; (A.V.); (I.V.S.); (M.M.D.)
- LEPABE—Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, 4099-002 Porto, Portugal
| | - Inês V. Silva
- CBQF—Centro de Biotecnologia e Química Fina—Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, 4169-005 Porto, Portugal; (A.V.); (I.V.S.); (M.M.D.)
| | - Marta M. Duarte
- CBQF—Centro de Biotecnologia e Química Fina—Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, 4169-005 Porto, Portugal; (A.V.); (I.V.S.); (M.M.D.)
| | - Ana L. Oliveira
- CBQF—Centro de Biotecnologia e Química Fina—Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, 4169-005 Porto, Portugal; (A.V.); (I.V.S.); (M.M.D.)
| |
Collapse
|
11
|
Liu T, Aman A, Ainiwaer M, Ding L, Zhang F, Hu Q, Song Y, Ni Y, Tang X. Evaluation of the anti-biofilm effect of poloxamer-based thermoreversible gel of silver nanoparticles as a potential medication for root canal therapy. Sci Rep 2021; 11:12577. [PMID: 34131273 PMCID: PMC8206346 DOI: 10.1038/s41598-021-92081-7] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2020] [Accepted: 05/21/2021] [Indexed: 12/19/2022] Open
Abstract
The purpose of this study was to design silver nanoparticles (AgNPs) poloxamer thermoreversible gel (AgNPs-PL) and investigate whether this gel could provide sustained antibacterial activity against Enterococcus faecalis (E. faecalis) in the root canal. The gels fabricated were characterized in terms of gelatin temperature, particle size, in-vitro Ag+ release, and elemental content. Cytotoxicity of AgNPs-PL on primary human periodontal ligament fibroblasts (HPDLFs) was examined by CCK-8 assay. Characterization of AgNPs-PL gel revealed that it contained particles existing as large clumps/fused aggregates of different shapes, with a mean diameter of 21.624 ± 14.689 nm, exhibited sustained release of Ag+ for 9 days, and non-toxic to HPDLFs at a low dose (4–32 μg/mL) through 24, 48, and 72 h exposures. The antibacterial effect of 16 and 32 μg/mL concentrations of AgNPs-PL was compared with blank poloxamer gel (PL) and calcium hydroxide (CH) using three methods: (I) agar counting plate, (II) scanning electron microscope (SEM) observations, and (III) confocal laser scanning microscope (CLSM) analysis. AgNPs-PL at the two doses above was more effective than PL and CH in removing E. faecalis biofilm at 1, 3, 9 days. Thus, AgNPs-PL exhibits strong activity against E. faecalis and is easy to produce, with a continuous release profile of Ag+. AgNPs-PL gel may be a candidate for a new root canal disinfection.
Collapse
Affiliation(s)
- Ting Liu
- Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.,Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China
| | - Aerdake Aman
- Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.,Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China
| | - Muniremu Ainiwaer
- Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.,Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China
| | - Liang Ding
- Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China
| | - Fei Zhang
- Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.,Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China
| | - Qingang Hu
- Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.,Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China
| | - Yuxian Song
- Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China
| | - Yanhong Ni
- Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China
| | - Xuna Tang
- Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China. .,Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China. .,Department of Endodontology, Nanjing Stomatological Hospital, No. 30 Zhongyang Road, Nanjing, People's Republic of China.
| |
Collapse
|
12
|
Beard MC, Cobb LH, Grant CS, Varadarajan A, Henry T, Swanson EA, Kundu S, Priddy LB. Autoclaving of Poloxamer 407 hydrogel and its use as a drug delivery vehicle. J Biomed Mater Res B Appl Biomater 2021; 109:338-347. [PMID: 32827204 PMCID: PMC8221373 DOI: 10.1002/jbm.b.34703] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2020] [Revised: 07/21/2020] [Accepted: 08/04/2020] [Indexed: 01/01/2023]
Abstract
With antibiotic-resistant bacteria becoming increasingly prevalent, biomaterials capable of targeted, in situ drug delivery are urgently needed. The synthetic polymer Poloxamer 407 (P407) is of particular interest due to its thermoreversible gelation. Clinical use of P407 typically involves sterilization via autoclaving, but the effects of these extreme environmental conditions on hydrogel water content, rheological properties and efficacy as a drug delivery vehicle remain unknown. The aim of this study was to investigate the effects of autoclaving on the properties of P407 hydrogel. Autoclaving reduced hydrogel water content due to evaporation, thus increasing the polymer weight fraction of the hydrogels. In contrast, except for a reduction in gelation temperature following autoclaving, autoclaved hydrogels had similar rheological properties as nonautoclaved hydrogels. In vitro, autoclaving did not hinder the hydrogel's efficacy as a carrier for vancomycin antibiotic, and P407 (with and without vancomycin) had a bactericidal effect on planktonic Staphylococcus aureus. An in vivo pilot study using P407 to deliver bacteriophage highlighted the need for additional understanding of the functionality of the hydrogel for surgical applications. In conclusion, P407 hydrogel water content and gelation temperature were reduced by autoclave sterilization, while other rheological properties and the efficacy of the biomaterial as a delivery vehicle for vancomycin in vitro were unaffected.
Collapse
Affiliation(s)
- Mary Catherine Beard
- Department of Agricultural and Biological Engineering, Mississippi State University, Starkville, Mississippi
| | - Leah H. Cobb
- Department of Agricultural and Biological Engineering, Mississippi State University, Starkville, Mississippi
| | - Christine S. Grant
- Department of Agricultural and Biological Engineering, Mississippi State University, Starkville, Mississippi
| | - Anandavalli Varadarajan
- Dave C. Swalm School of Chemical Engineering, Mississippi State University, Starkville, Mississippi
| | - Taylor Henry
- Dave C. Swalm School of Chemical Engineering, Mississippi State University, Starkville, Mississippi
| | - Elizabeth A. Swanson
- Department of Clinical Sciences, College of Veterinary Medicine, Mississippi State University, Starkville, Mississippi
| | - Santanu Kundu
- Dave C. Swalm School of Chemical Engineering, Mississippi State University, Starkville, Mississippi
| | - Lauren B. Priddy
- Department of Agricultural and Biological Engineering, Mississippi State University, Starkville, Mississippi
| |
Collapse
|
13
|
A hydrogel system based on a lactose-modified chitosan for viscosupplementation in osteoarthritis. Carbohydr Polym 2020; 248:116787. [DOI: 10.1016/j.carbpol.2020.116787] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2020] [Revised: 07/15/2020] [Accepted: 07/16/2020] [Indexed: 01/16/2023]
|
14
|
Zielińska A, Soles BB, Lopes AR, Vaz BF, Rodrigues CM, Alves TFR, Klensporf-Pawlik D, Durazzo A, Lucarini M, Severino P, Santini A, Chaud MV, Souto EB. Nanopharmaceuticals for Eye Administration: Sterilization, Depyrogenation and Clinical Applications. BIOLOGY 2020; 9:biology9100336. [PMID: 33066555 PMCID: PMC7602230 DOI: 10.3390/biology9100336] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/11/2020] [Revised: 09/23/2020] [Accepted: 10/13/2020] [Indexed: 12/11/2022]
Abstract
Simple Summary Nanopharmaceuticals have revolutionized the way ophthalmic drugs are administered to overcome ocular delivery barriers and improve drug bioavailability. The design and production of an efficient ocular drug delivery system still remain a challenge. In this review, we discuss the sterilization and depyrogenation methods, commonly used for ophthalmic nanopharmaceuticals, and their clinical applications. Abstract As an immune-privileged target organ, the eyes have important superficial and internal barriers, protecting them from physical and chemical damage from exogenous and/or endogenous origins that would cause injury to visual acuity or even vision loss. These anatomic, physiological and histologic barriers are thus a challenge for drug access and entry into the eye. Novel therapeutic concepts are highly desirable for eye treatment. The design of an efficient ocular drug delivery system still remains a challenge. Although nanotechnology may offer the ability to detect and treat eye diseases, successful treatment approaches are still in demand. The growing interest in nanopharmaceuticals offers the opportunity to improve ophthalmic treatments. Besides their size, which needs to be critically monitored, nanopharmaceuticals for ophthalmic applications have to be produced under sterilized conditions. In this work, we have revised the different sterilization and depyrogenation methods for ophthalmic nanopharmaceuticals with their merits and drawbacks. The paper also describes clinical sterilization of drugs and the outcomes of inappropriate practices, while recent applications of nanopharmaceuticals for ocular drug delivery are also addressed.
Collapse
Affiliation(s)
- Aleksandra Zielińska
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal; (A.Z.); (B.B.S.); (A.R.L.); (B.F.V.); (C.M.R.)
- Institute of Human Genetics, Polish Academy of Sciences, Strzeszyńska 32, 60-479 Poznań, Poland
| | - Beatriz B. Soles
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal; (A.Z.); (B.B.S.); (A.R.L.); (B.F.V.); (C.M.R.)
| | - Ana R. Lopes
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal; (A.Z.); (B.B.S.); (A.R.L.); (B.F.V.); (C.M.R.)
| | - Beatriz F. Vaz
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal; (A.Z.); (B.B.S.); (A.R.L.); (B.F.V.); (C.M.R.)
| | - Camila M. Rodrigues
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal; (A.Z.); (B.B.S.); (A.R.L.); (B.F.V.); (C.M.R.)
| | - Thais F. R. Alves
- Laboratory of Biomaterial and Nanotechnology (LaBNUS). University of Sorocaba, Raposo Tavares 92.5, Sorocaba, 18078-005 São Paulo, Brazil;
| | - Dorota Klensporf-Pawlik
- Institute of Quality Science, Poznań University of Economics and Business, al. Niepodległości 10, 61-875 Poznań, Poland;
| | - Alessandra Durazzo
- CREA-Research Centre for Food and Nutrition, Via Ardeatina 546, 00178 Rome, Italy; (A.D.); (M.L.)
| | - Massimo Lucarini
- CREA-Research Centre for Food and Nutrition, Via Ardeatina 546, 00178 Rome, Italy; (A.D.); (M.L.)
| | - Patricia Severino
- Center for Biomedical Engineering, Department of Medicine, Brigham and Women& Hospital, Harvard Medical School, 65 Landsdowne Street, Cambridge, MA 02139, USA;
- Biotechnological Postgraduate Program, University of Tiradentes (Unit), Av. Murilo Dantas, 300, 49010-390 Aracaju, Brazil
- Institute of Technology and Research (ITP), Nanomedicine and Nanotechnology Laboratory (LNMed), Av. Murilo Dantas, 300, 49010-390 Aracaju, Brazil
- Tiradentes Institute, 150 Mt Vernon St, Dorchester, MA 02125, USA
| | - Antonello Santini
- Department of Pharmacy, University of Napoli Federico II, 80131 Napoli, Italy
- Correspondence: (A.S.); (M.V.C.); (E.B.S.); Tel.: +39-81-253-9317 (A.S.); +55-15-98172-4431 (M.V.C.); +351-239-488-400 (E.B.S.)
| | - Marco V. Chaud
- Laboratory of Biomaterial and Nanotechnology (LaBNUS). University of Sorocaba, Raposo Tavares 92.5, Sorocaba, 18078-005 São Paulo, Brazil;
- Correspondence: (A.S.); (M.V.C.); (E.B.S.); Tel.: +39-81-253-9317 (A.S.); +55-15-98172-4431 (M.V.C.); +351-239-488-400 (E.B.S.)
| | - Eliana B. Souto
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal; (A.Z.); (B.B.S.); (A.R.L.); (B.F.V.); (C.M.R.)
- CEB—Centre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal
- Correspondence: (A.S.); (M.V.C.); (E.B.S.); Tel.: +39-81-253-9317 (A.S.); +55-15-98172-4431 (M.V.C.); +351-239-488-400 (E.B.S.)
| |
Collapse
|
15
|
Kad A, Pundir A, Arya SK, Bhardwaj N, Khatri M. An Elucidative Review to Analytically Sieve the Viability of Nanomedicine Market. J Pharm Innov 2020; 17:249-265. [PMID: 32983280 PMCID: PMC7502307 DOI: 10.1007/s12247-020-09495-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/08/2020] [Indexed: 12/19/2022]
Abstract
The advent of the twenty-first century marked a paradigm shift in the healthcare sector with coming of automated, sensitive, targeted medicines and technologies having diagnostic, prophylactic and therapeutic effects. Nanomedicines also attained wide acclamation in their initial years, but the transformation from being the proof of concept to successfully marketed products seems very daunting. Although the reason for this may be attributed to slow but incremental character of many present-day technologies, the review asserts that there are other significant facets that may purvey a thorough explanation of this scenario. The article elaborately discusses the hurdles hindering clinical translation of nanomedicines including scale-up challenges, in vitro in vivo cascade of toxicology assays, along with unrefined manufacturing guidelines, inadequate regulatory approvals, competitive conventional market, etc., leading to hesitant investments by pharmaceutical giants. The paper also explores the economic viability of nanobiotechnology sector through an empirical investigation of the revenue data of various pharmaceutical industries manufacturing nano-based drugs, which indicates minor commercial importance of these medicines. We also laid down a comprehensive set of recommendations to smoothen the translational pathway of nanomedicines from an idea to reality, efface the consumer distrust and push boundaries for development and launching of safe, efficient and commercially successful products. Graphical abstract.
Collapse
Affiliation(s)
- Anaida Kad
- Department of Biotechnology, University Institute of Engineering and Technology, Panjab University, Sector-25, Chandigarh, 160014 India
| | - Archit Pundir
- Department of Biotechnology, University Institute of Engineering and Technology, Panjab University, Sector-25, Chandigarh, 160014 India
| | - Shailendra Kumar Arya
- Department of Biotechnology, University Institute of Engineering and Technology, Panjab University, Sector-25, Chandigarh, 160014 India
| | - Neha Bhardwaj
- Department of Biotechnology, University Institute of Engineering and Technology, Panjab University, Sector-25, Chandigarh, 160014 India
| | - Madhu Khatri
- Department of Biotechnology, University Institute of Engineering and Technology, Panjab University, Sector-25, Chandigarh, 160014 India
- Wellcome Trust/DBT IA Early Career Fellow, Panjab University, Chandigarh, 160014 India
| |
Collapse
|
16
|
Abstract
Hydrogels, swellable hydrophilic polymer networks fabricated through chemical cross-linking or physical entanglement are increasingly utilized in various biomedical applications over the past few decades. Hydrogel-based microparticles, dressings and microneedle patches have been explored to achieve safe, sustained and on-demand therapeutic purposes toward numerous skin pathologies, through incorporation of stimuli-responsive moieties and therapeutic agents. More recently, these platforms are expanded to fulfill the diagnostic and monitoring role. Herein, the development of hydrogel technology to achieve diagnosis and monitoring of pathological skin conditions are highlighted, with proteins, nucleic acids, metabolites, and reactive species employed as target biomarkers, among others. The scope of this review includes the characteristics of hydrogel materials, its fabrication procedures, examples of diagnostic studies, as well as discussion pertaining clinical translation of hydrogel systems.
Collapse
|
17
|
Sattari S, Beyranvand S, Soleimani K, Rossoli K, Salahi P, Donskyi IS, Shams A, Unger WES, Yari A, Farjanikish G, Nayebzadeh H, Adeli M. Boronic Acid-Functionalized Two-Dimensional MoS 2 at Biointerfaces. LANGMUIR : THE ACS JOURNAL OF SURFACES AND COLLOIDS 2020; 36:6706-6715. [PMID: 32441938 DOI: 10.1021/acs.langmuir.0c00776] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
While noncovalent interactions at two-dimensional nanobiointerfaces are extensively investigated, less knowledge about covalent interactions at this interface is available. In this work, boronic acid-functionalized 2D MoS2 was synthesized and its covalent multivalent interactions with bacteria and nematodes were investigated. Polymerization of glycidol by freshly exfoliated MoS2 and condensation of 2,5-thiophenediylbisboronic acid on the produced platform resulted in boronic acid-functionalized 2D MoS2. The destructive interactions between 2D MoS2 and bacteria as well as nematodes were significantly amplified by boronic acid functional groups. Because of the high antibacterial and antinematodal activities of boronic acid-functionalized 2D MoS2, its therapeutic efficacy for diabetic wound healing was investigated. The infected diabetic wounds were completely healed 10 days after treatment with boronic acid-functionalized 2D MoS2, and a normal structure for recovered tissues including different layers of skin, collagen, and blood vessels was detected.
Collapse
Affiliation(s)
- Shabnam Sattari
- Department of Chemistry, Faculty of Science, Lorestan University, Khorramabad 0663332145, Iran
| | - Siamak Beyranvand
- Department of Chemistry, Faculty of Science, Lorestan University, Khorramabad 0663332145, Iran
| | - Khadijeh Soleimani
- Department of Chemistry, Faculty of Science, Lorestan University, Khorramabad 0663332145, Iran
| | - Kiarash Rossoli
- Department of Pathobiology, Faculty of Veterinary Medicine, Lorestan University, Khorramabad 0663332145, Iran
| | - Pouya Salahi
- Department of Pathobiology, Faculty of Veterinary Medicine, Lorestan University, Khorramabad 0663332145, Iran
| | - Ievgen S Donskyi
- Institut für Chemie und Biochemie, Freie Universität Berlin, Takustr. 3, Berlin 14195, Germany
- BAM-Federal Institute for Material Science and Testing, Division 6.1, Surface Analysis and Interfacial Chemistry, Unter den Eichen 44-46, Berlin 12205, Germany
| | - Azim Shams
- Department of Chemistry, Faculty of Science, Lorestan University, Khorramabad 0663332145, Iran
| | - Wolfgang E S Unger
- BAM-Federal Institute for Material Science and Testing, Division 6.1, Surface Analysis and Interfacial Chemistry, Unter den Eichen 44-46, Berlin 12205, Germany
| | - Abdolah Yari
- Department of Chemistry, Faculty of Science, Lorestan University, Khorramabad 0663332145, Iran
| | - Ghasem Farjanikish
- Department of Pathobiology, Faculty of Veterinary Medicine, Lorestan University, Khorramabad 0663332145, Iran
| | - Hassan Nayebzadeh
- Department of Pathobiology, Faculty of Veterinary Medicine, Lorestan University, Khorramabad 0663332145, Iran
| | - Mohsen Adeli
- Department of Chemistry, Faculty of Science, Lorestan University, Khorramabad 0663332145, Iran
| |
Collapse
|
18
|
Li R, Peng F, Cai J, Yang D, Zhang P. Redox dual-stimuli responsive drug delivery systems for improving tumor-targeting ability and reducing adverse side effects. Asian J Pharm Sci 2020; 15:311-325. [PMID: 32636949 PMCID: PMC7327776 DOI: 10.1016/j.ajps.2019.06.003] [Citation(s) in RCA: 62] [Impact Index Per Article: 15.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2019] [Revised: 03/28/2019] [Accepted: 06/20/2019] [Indexed: 01/23/2023] Open
Abstract
Cancer is a big challenge that has plagued the human beings for ages and one of the most effective treatments is chemotherapy. However, the low tumor-targeting ability limits the wide clinical application of chemotherapy. The microenvironment plays a critical role in many aspects of tumor genesis. It generates the tumor vasculature and it is highly implicated in the progression to metastasis. To maintain a suitable environment for tumor progression, there are special microenvironment in tumor cell, such as low pH, high level of glutathione (GSH) and reactive oxygen species (ROS), and more special enzymes, which is different to normal cell. Microenvironment-targeted therapy strategy could create new opportunities for therapeutic targeting. Compared to other targeting strategies, microenvironment-targeted therapy strategy will control the drug release into tumor cells more accurately. Redox responsive drug delivery systems (DDSs) are developed based on the high level of GSH in tumor cells. However, there are also GSH in normal cell though its level is lower. In order to control the release of drugs more accurately and reduce side effects, other drug release stimuli have been introduced to redox responsive DDSs. Under the synergistic reaction of two stimuli, redox dual-stimuli responsive DDSs will control the release of drugs more accurately and quickly and even increase the accumulation. This review summarizes strategies of redox dual-stimuli responsive DDSs such as pH, light, enzyme, ROS, and magnetic guide to delivery chemotherapeutic agents more accurately, aiming at providing new ideas for further promoting the drug release, enhancing tumor-targeting and improving anticancer effects. To better illustrate the redox dual-stimuli responsive DDS, preparations of carriers are also briefly described in the review.
Collapse
Affiliation(s)
- Ruirui Li
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China
| | - Feifei Peng
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China
| | - Jia Cai
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China
| | - Dandan Yang
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China
| | - Peng Zhang
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China
| |
Collapse
|
19
|
Stojkovska J, Zvicer J, Obradovic B. Preclinical functional characterization methods of nanocomposite hydrogels containing silver nanoparticles for biomedical applications. Appl Microbiol Biotechnol 2020; 104:4643-4658. [DOI: 10.1007/s00253-020-10521-2] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2020] [Revised: 01/04/2020] [Accepted: 03/03/2020] [Indexed: 12/20/2022]
|